Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1477-1485

  Wolfe, Frederick ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

C reactive protein; disease activity; erythrocyte sedimentation rate; rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ALPHA 1-ANTITRYPSIN; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; GLOBINS; HUMANS; MALE; MIDDLE AGED; PREALBUMIN; REFERENCE VALUES; RHEUMATOID FACTOR; ROC CURVE; SERUM ALBUMIN;

EID: 0030749194     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. van der Heijde DMFM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LBA: Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
2. Wolfe F: The clinical and research significance of the erythrocyte sedimentation rate (letter). Weinstein A: Reply. J Rheumatol 1995;22:788-9.
3. Bird HA, Esselinckx W, StJ Dixon AG, Mowat AG, Wood PHN: An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
4. Altman RD, Alarcón GS, Appelrouth D, et al: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
5. Pinals RS, Baum J, Bland J, et al: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
6. Williams HJ, Ward JR, Reading JC, et al: Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1992;35:259-69.
7. Anonymous, Etodolac vs diclofenac protocol 654A-328-US. 1992.
8. Kushner I, Rzewnicki DL: The acute phase response - general aspects. Baillieres Clin Rheumatol 1994;8:513-30.
9. Wolfe F, Michaud K: The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37.
10. Weinstein A, Delgiudice J: The erythrocyte sedimentation rate -Time honored and tradition bound. J Rheumatol 1994;21:1177-8.
11. Kushner I: C-reactive protein in rheumatology. Arthritis Rheum 1991;34:1065-8.
12. van Leeuwen MA, van Rijswijk MH: Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin Rheumatol 1994;8:531-52.
13. Ballou SP, Kushner I: C-reactive protein and the acute phase response. Adv Intern Med 1992;37:313-36.
14. Hassell AB, Davis MJ, Fowler PD, et al: The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med 1993;86:601-7.
15. Mottonen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
16. Grindulis KA, Calverley M, Constable TJ, Forster PJ, Ahmed ME, McConkey B: A comparison between clinical and laboratory tests in rheumatoid arthritis. Scand J Rheumatol 1983;12:285-8.
17. Blackburn WD Jr: Validity of acute phase proteins as markers of disease activity. J Rheumatol 1994;(suppl 42)21:9-13.
18. McConkey B, Davies P, Crockson RA, et al: Effects of gold, dapsone and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in RA. Ann Rheum Dis 1979;38:141-4.
19. Van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ: Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
20. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al: The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease. Br J Rheumatol 1993;(suppl 3)32:9-13.
21. Goldsmith CH, Smythe HA, Helewa A: Interpretation and power of a pooled index. J Rheumatol 1993;20:575-8.
22. van der Heijde DMFM, van't Hof M, van Riel PL, van de Putte LBA: Validity of single variables and indices to measure disease activity in rheumatoid arthritis. J Rheumatol 1993;20:538-41.
23. Anderson JJ, Felson DT, Meenan RF, Williams HJ: Which traditional measures should be used in rheumatoid arthritis clinical trials. Arthritis Rheum 1989;32:1093-9.
24. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
25. Felson DT, Anderson JJ, Boers M, et al: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:129-40.
26. Wolfe F, Hawley DJ, Wilson K: The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
27. Altman R, Asch E, Bloch DA, et al: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
28. Altman RD, Alarcón GS, Appelrouth D, et al: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33:1601-10.
29. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
31. Wolfe F: Data collection and utilization: A methodology for clinical practice and clinical research. In: Wolfe F, Pincus T, eds. Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:463-514.
32. Fries JF, Spitz PW, Kraines RG: Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
33. Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF: The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988;15:1480-8.
34. Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: A 10 year longitudinal study of 6,608 rheumatic disease patients. J Rheumatol 1993;20:2025-31.
35. Decker JL, McShane DJ, Esdaile JM, et al: Dictionary of the Rheumatic Diseases, vol I: Signs and symptoms. New York: Contact Associates International, 1982.
36. Wolfe F, Cathey MA, Roberts FK: The latex test revisited -rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum 1991;34:951-60.
37. Böttiger LE, Svedberg CA: Normal erythrocyte sedimentation rate and age. BMJ 1967;2:85-7.
38. Miller A, Green M, Robinson D: Short rule for calculating normal erythrocyte sedimentation rate. BMJ 1983;286:266.
39. Rafnsson V, Bengtsson C, Lennartson J, Lindquist O, Noppa H, Tipplin E: Erythrocyte sedimentation rate in a population sample of women with special reference to its clinical and prognostic significance. Acta Med Scand 1979;206:201-14.
40. Stata Corporation: Stata Statistical Software: Release 4.0. College Station, TX: Stata Corporation, 1995.
41. Metz CE, Herman B, Shen J, Kronman HB, Wang P: CLABROC - A computer program to compare ROC curves. 1993;[ftp to random.bsd.uchicago.edu (use anonymous).]
42. Hatcher L: A step-by-step approach to using the SAS System for factor analysis and structural equation modeling. Cary: SAS Institute, 1994;28-9.
43. Cuzick J: A Wilcoxon-type test for trend. Statistics in Medicine 1985;4:81-90.
44. Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B: Rheumatoid arthritis: Relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1977;1:195-7.